Amundi
TDOC icon

Amundi’s Teladoc Health TDOC Stock Holding History

Amundi’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,577
Closed -$236K – 2013
2024
Q2 		$236K Sell
25,577
-6,592
-20% -$80.4K ﹤0.01% 1541
2024
Q1 		$424K Sell
32,169
-490
-2% -$8.89K ﹤0.01% 1466
2023
Q4 		$712K Sell
32,659
-448
-1% -$8.27K ﹤0.01% 1380
2023
Q3 		$613K Buy
33,107
+672
+2% +$15.7K ﹤0.01% 1382
2023
Q2 		$831K Sell
32,435
-305
-0.9% -$7.68K ﹤0.01% 1302
2023
Q1 		$845K Sell
32,740
-103,464
-76% -$2.77M ﹤0.01% 1276
2022
Q4 		$3.44M Sell
136,204
-144,832
-52% -$3.91M ﹤0.01% 1086
2022
Q3 		$7.6M Sell
281,036
-15,589
-5% -$547K ﹤0.01% 886
2022
Q2 		$11.6M Buy
296,625
+10,699
+4% +$454K 0.01% 741
2022
Q1 		$19.7M Sell
285,926
-170,999
-37% -$12.3M 0.01% 668
2021
Q4 		$35.9M Sell
456,925
-866,243
-65% -$104M 0.02% 544
2021
Q3 		$168M Buy
1,323,168
+429,955
+48% +$62.6M 0.12% 203
2021
Q2 		$149M Buy
+893,213
New +$145M 0.1% 210

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Amundi's TDOC Position: Q3 2024 in Review

Amundi sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 25,577 shares — an estimated $236K sold.

Amundi first reported a position in TDOC in Q2 2021 and held it in 13 quarters. The position peaked at $168M in Q3 2021. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Amundi reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Amundi sold 25,577 Teladoc Health shares in Q3 2024, an estimated $236K.
  • Amundi first reported a position in Teladoc Health in Q2 2021 and held it in 13 quarters.
  • Amundi's Teladoc Health position peaked at $168M in Q3 2021.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Amundi's 13F filing for Q3 2024, filed 13 Nov 2024.